Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.

Documenti analoghi

• Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection
  di: Hamlyn, E, et al.
  Pubblicazione: (2012)
• Low-level viremia episodes appear to affect the provirus composition of the circulating cellular HIV reservoir during antiretroviral therapy
  di: Xiao Sun, et al.
  Pubblicazione: (2024-05-01)
• Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy
  di: Kroeze, S, et al.
  Pubblicazione: (2020)
• Viremia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy
  di: Dorward, J, et al.
  Pubblicazione: (2024)
• Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimod
  di: Mohamed Abdel-Mohsen, et al.
  Pubblicazione: (2024-06-01)